Ann: Quarterly Results and Investor Conference Call Notification, page-19

That was the best quarterly conference in terms of questions asked. To be honest, I didn't learn a lot more from it, but it's still valuable tuning in. I was hoping we may get some usage information if/when Medgate signed, but it sounds like it will be just some high-level contract announcement. It will be interesting if there is a comment about 'significant revenue' though. That's probably the best we can hope for.

Other than that, the phosphorous study is running slower than expected, but we should get an update in August. They also want to expand the volume and breadth of the study, so it sounds like any confirmation RAP can predict covid wont be available until the end of the year.